<it>Schistosoma haematobium</it> infections among schoolchildren in central Sudan one year after treatment with praziquantel

<it>Schistosoma haematobium</it> infections among schoolchildren in central Sudan one year after treatment with praziquantel

<p>Abstract</p> <p>Background</p> <p>Chemotherapy with praziquantel (PZQ) is the mainstay of schistosomiasis control. However, there are recent concerns about tolerance or resistance to PZQ, so that monitoring its efficacy in different settings is required.</p> &l...

Full description

Bibliographic Details
Main Authors:	Ahmed Abedaziz M, Abbas Hana, Mansour Fathi A, Gasim Gasim I, Adam Ishag
Format:	Article
Language:	English
Published:	BMC 2012-06-01
Series:	Parasites & Vectors
Online Access:	http://www.parasitesandvectors.com/content/5/1/108

Similar Items

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
by: Jennifer Keiser, et al.
Published: (2014-07-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: G.C. Coles, et al.
Published: (2001-12-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01)

Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children.
by: Mahamadou S Sissoko, et al.
Published: (2009-10-01)

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

Haematological and Biochemical Morbidity of Schistosoma Haematobium in School Children in Sudan
by: Elagba HA Mohammed, et al.
Published: (2006-12-01)

Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis
by: Ishag Adam, et al.
Published: (2018-03-01)

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa
by: Iran Mendonça da Silva, et al.
Published: (2005-07-01)

Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium
by: Chalotte Willemann Stecher, et al.
Published: (2017-11-01)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
by: Calvin Bisong Ebai, et al.
Published: (2017-12-01)

Tuberculin reactivity in schoolchildren, Kassala State, Sudan
by: Fatima Abbas Khalid, et al.
Published: (2020-01-01)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
by: Jana Kovač, et al.
Published: (2017-08-01)

Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
by: Jean T Coulibaly, et al.
Published: (2012-01-01)

Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
by: Bridget W Kimani, et al.
Published: (2018-10-01)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2019-12-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

Patterns of <it>Schistosoma haematobium </it>infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa
by: Kvalsvig Jane D, et al.
Published: (2004-10-01)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
by: Beatrice Barda, et al.
Published: (2016-09-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya--Reply to Drs. Coles, Liang, and Doenhoff
by: C. H. King, et al.
Published: (2001-12-01)

Dynamics of <it>Schistosoma haematobium </it>egg output and associated infection parameters following treatment with praziquantel in school-aged children
by: Stete Katarina, et al.
Published: (2012-12-01)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2021-06-01)

Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
by: Samuel Nkansah Darko, et al.
Published: (2020-05-01)

High Efficacy of Praziquantel in Schistosoma haematobium-Infected Children in Taraba State, Northeast Nigeria: A follow-up study
by: Robert S. Houmsou, et al.
Published: (2018-12-01)

Spatial distribution and risk factors of Schistosoma haematobium and hookworm infections among schoolchildren in Kwale, Kenya.
by: Evans Asena Chadeka, et al.
Published: (2017-09-01)

Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01)

CRISPR-assisted test for Schistosoma haematobium
by: Dounia Cherkaoui, et al.
Published: (2023-03-01)

Colon polyps in Schistosoma haematobium schistosomiasis
by: Celso Alberto Chassot, et al.
Published: (1998-01-01)

Schistosoma haematobium Infection and Buruli Ulcer
by: Janet T. Scott, et al.
Published: (2004-03-01)

The usefulness of indirect diagnostic tests for Schistosoma haematobium infection after repeated rounds of mass treatment with praziquantel in Mpwapwa and Chakechake districts in Tanzania
by: Billy Ngasala, et al.
Published: (2020-01-01)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
by: Angora Etienne K., et al.
Published: (2022-01-01)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
by: Eglal I. Amer, et al.
Published: (2022-03-01)

Genetic manipulation of Schistosoma haematobium, the neglected schistosome.
by: Gabriel Rinaldi, et al.
Published: (2011-10-01)

The small RNA complement of adult Schistosoma haematobium.
by: Andreas J Stroehlein, et al.
Published: (2018-05-01)

Dynamics in Morbidity Markers and Cytological Observations Made in Urine of <i>Schistosoma haematobium</i>-Infected Children: Pre- and Post-Praziquantel Treatment in an Endemic Setting
by: Patience B. Tetteh-Quarcoo, et al.
Published: (2022-02-01)

Downregulation of MIP-1α/CCL3 with praziquantel treatment in <it>Schistosoma haematobium </it>and HIV-1 co-infected individuals in a rural community in Zimbabwe
by: Ullum H, et al.
Published: (2009-10-01)

Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
by: Nada Abdel Aziz, et al.
Published: (2019-12-01)

Schistosoma haematobium–Schistosoma mansoni Hybrid Parasite in Migrant Boy, France, 2017
by: Yohann Le Govic, et al.
Published: (2019-02-01)

HESTOPATHOGLOGICAL STUDIES ON MIGRATION OF SCHISTOSOMA HAEMATOBIUM AND SCHISTOSOMA MANSONI LARVAE IN LABORATORY ANIMALS
by: M.R.Nazari, et al.
Published: (1985-06-01)

Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya.
by: Kariuki H Njaanake, et al.
Published: (2023-01-01)